Biologic & viral-vector quantification simplified
Accurate titre data… at your convenience
Biologic & viral-vector quantification simplified
Accurate titre data… at your convenience
Introducing Amperia – effortless agile protein quantification and binding assays
Quantify antibodies, AAVs and other proteins directly from crude samples in as little as 1 minute per sample conveniently at your bench or bioreactor. Make fast, confident decisions with access to robust titre data wherever and whenever you need it, so that you can focus on driving impact and innovation in your protein research, cell line development and bioprocess development.
Our compact ‘all-in-one’ automated Amperia instrument is designed to free you from manual methods and analytical delays and empower every lab with real-time data to optimise workflows. Save valuable time and resources without compromising on quality analytics.
Discover a new approach to simplify protein quantification.
1
As little as 1 minute assay time per sample
96
Test crude samples in standard 96-well plates
4
Automated processing;
4 samples in parallel
40
Deploy at-line; compact 40×40 cm
Simple protein quantification with RED – a new approach
Amperia utilises proprietary Redox Electrochemical Detection (RED). Protein binding is translated into an electrical signal and read immediately. No optical components mean a compact footprint and low maintenance. Detection is highly sensitive and specific, enabling quantification in complex samples without purification.
Comparable accuracy with BLI and SPR in cell line development
Agenus UK, a clinical-stage biopharmaceutical company, evaluated the performance of Amperia RED technology for human antibody quantification as part of a cell line development program, demonstrating comparable accuracy to Bio-Layer Interferometry (BLI) and Surface Plasmon Resonance (SPR) methods, but greater operational efficiency due to at-line analysis.
Accurate automated AAV quantification, 3x faster than manual ELISA
The accuracy, reproducibility and efficiency of the Amperia RED system was compared with manual ELISA methods for AAV capsid titre in a recent study. The Amperia system demonstrated greater accuracy and consistency in titre measurements at multiple sample concentrations across three test days, and a 3 x faster time to result.
University of Manchester efficiently isolates 10x higher-producing CHO population using Amperia
The team needed to assess antibody titre in 100s of samples, but extensive manual ELISA processing meant cell cultures were frozen to manage throughput and data was retrospective. Using the Amperia allowed the team to obtain same day titre results, expedite decisions and reduce project timelines by around 40%.
Ready for real-time data?
See how Amperia can accelerate your workflow. Contact us to learn more or schedule a demo.
Read our latest news
NHS Blood and Transplant Clinical Biotechnology Centre implements the Amperia system to streamline viral vector process development for novel gene therapies The NHSBT Clinical Biotechnology Centre (CBC), Bristol, one of three government selected Innovation Hubs tasked...
Published April 9, 2025 - We’re excited to share that Abselion is featured in the Spring 2025 issue of Innovations in Pharmaceutical Technology (IPT), highlighting the role of our Amperia system in advancing at-line protein quantification for biologics and viral...
